Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19-associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults With COVID-19

NCT04360824 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT04360824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04360824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19-associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults With COVID-19
Lead sponsor
University of Iowa
Phase
Phase 4
Overall status
Completed
Start date
May 6, 2020
Completion date
April 16, 2021
Enrollment
176 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19 associated coagulopathy